CN Stock MarketDetailed Quotes

300765 CSPC Innovation Pharmaceutical

Watchlist
  • 41.91
  • +2.31+5.83%
Market Closed Apr 30 15:00 CST
58.87BMarket Cap-1132.70P/E (TTM)

About CSPC Innovation Pharmaceutical Company

The company is a subsidiary of Hong Kong Hang Seng Index Stock Pharmaceutical Group, and has now developed into an innovative company integrating biopharmaceuticals, APIs and functional foods. The company's main business is R&D, production and sales of biopharmaceuticals and functional foods and raw materials. The main products are ADC, mRNA vaccines, antibody drugs, caffeine, vitamin C tablets, etc. The company has received honors such as the Hebei Enterprise Technology Center, the Hebei Science and Technology Achievement Award, and the 2018 Hebei Patent Award Excellence Award.

Company Profile

Short Name-A新诺威
Symbol-A300765
Company NameCSPC Innovation Pharmaceutical Co.,Ltd.
Listing DateMar 22, 2019
Issue Price24.47
Shares Offered50.00M share(s)
FoundedApr 5, 2006
Legal Representativebing yao
General Managerbing yao
Secretarylong dai
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativelong dai
Legal CounselBeijing Jun Zejun Law Firm
Employees853
Phone0311-67809843
Office AddressNo. 62, Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province
Zip Code051430
Registered AddressNo. 62, Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province
Fax0311-67809843
Email300765@mail.ecspc.com
Business License130100000144986
BusinessManufacture and sale of raw materials (caffeine, theophylline, aminophylline, dihydroxypropylline, theophylline, pentoxylline, pentoxylline), psychotropic drugs (caffeine); production and sale of food additives (caffeine); sales of pharmaceutical intermediates; production and sale of beverages; production and sale of health foods and confectionery products; wholesale and retail of prepackaged foods; prepackaged food, health food (excluding frozen food above) technology research and development, technology transfer, technical consulting, and technology promotion services; operating the enterprise's self-produced products and technology export business Raw materials needed by enterprises for production and scientific research The import business of materials, mechanical equipment, instruments, spare parts and related technology, with the exception of goods and technology operated by state-restricted companies and prohibited from being imported. (Matters prohibited or restricted by laws, regulations, and decisions of the State Council shall not be operated; matters requiring approval by other departments may not be operated until approved)

Company Executives

  • Name
  • Position
  • Salary
  • bing yao
  • Chairman, Directors, General Manager, Strategy Committee Convener, Nomination Committee Members
  • 538.40K
  • CAI LEI
  • Directors
  • --
  • wen xu
  • Directors, Audit Committee Member
  • --
  • long dai
  • Directors, Board Secretary, Securities Affairs Representative, Chief Financial Officer, Member of the Remuneration and Assessment Committee
  • 223.20K
  • feng han
  • Directors, Strategy Committee Member
  • 484.10K
  • jianping zhou
  • Independent Directors
  • 35.00K
  • dibin li
  • Independent Directors, Strategy Committee Member, Remuneration and Assessment Committee Convener
  • 60.00K
  • peng yang
  • Independent Directors, Audit Committee Member, Nomination Committee Convener
  • 60.00K
  • congzhi di
  • Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee, Nomination Committee Members
  • 60.00K
  • jiyong zhang
  • Chairman of the Supervisory Board, Auditors
  • --
  • ling zhang
  • Auditors
  • --
  • xiwu hui
  • Deputy General Manager
  • --
  • chunyi zhu
  • Head of Audit Department
  • --
  • bin yuan
  • Employee Supervisors
  • 154.70K

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More